Physician Photo

David T. Scadden, Jr., MD

Director, Center for Regenerative Medicine

Co-Director, Harvard Stem Cell Insitutite

Director, Hematologic Malignancies & Experimental Hematology

  • Phone: 617-726-5615
Department of Medicine


  • Cancer Center
  • Lymphoma
  • Multiple Myeloma
  • Hematology
  • Leukemia
Clinical Interests
Stem cells
Regenerative medicine
Hematologic malignancies
Boston: Massachusetts General Hospital
Medical Education
MD, Case Western Reserve University School of Medicine
Residency, Brigham and Women's Hospital
Fellowship, Brigham and Women's Hospital
Fellowship, Dana Farber Cancer Institute
Board Certifications
Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine
Hematology, American Board of Internal Medicine
Patient Age Group
Accepting New Patients
Accepting New Patients

ResearchMy interest is in understanding how stem cell biology can be used to develop more effective therapies for blood diseases and cancer.

Lifting the ban on stem cell funding

Dr. David Scadden shares his thoughts on the new executive order.

Donation enables advances at Center for Regenerative Medicine

MGH Hotline 05.14.10 Researchers from the Center for Regenerative Medicine gathered with Cheryl Chagnon, Heather Reid and their families April 6 to celebrate the donation of an important piece of research equipment -- the Nexelcom Cellometer Vision automatic cell analyzer.

In General: David Scadden, MD

MGH Hotline 08.06.10 In General awards and honors

In General

MGH Hotline 12.24.10 In General awards and honors

Students learn about stem cell research

MGH Hotline 5.27.11

In General 05.11.12

In General awards and honors

"Good" cells can go "bad" in a "bad neighborhood"

A new study by Harvard researchers at Massachusetts General Hospital indicates that “good” cells can become cancerous because of exposure to a “bad” environment within the body — similarly to the way a “good boy” may turn to crime when exposed to the pressures of life in a crime-ridden neighborhood.

MicroRNA molecule increases number of blood stem cells, may help improve cancer treatment

MGH investigators have identified a new mechanism that controls the number of the stem cells that give rise to all blood and immune system cells, an advance that may improve treatment of blood system cancers.

A non-toxic strategy to treat leukemia

A study comparing how blood stem cells and leukemia cells consume nutrients found that cancer cells are far less tolerant to shifts in their energy supply than their normal counterparts. The results suggest that there could be ways to target leukemia metabolism so that cancer cells die but other cell types are undisturbed.

Center for Regenerative Medicine
Harvard Stem Cell Institute
185 Cambridge Street
Boston, MA 02114

Phone: 617-726-5615
Fax: 617-724-2662